Plunkett Research Online: Omni Bio Pharmaceutical Inc

OMNI BIO PHARMACEUTICAL INC (OMBP:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Omni Bio Pharmaceutical, Inc. is the licensee of filed, but not yet issued, patents related to composition of matter and method of use for an existing FDA approved drug, Alpha 1 Antitrypsin (AAT), for treating organ transplantation, including islet transplantation for the treatment of diabetes and b.....



Omni Bio Pharmaceutical Inc
Ticker: OMBP
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 303 867-3415
Fax:
Address: 5350 South Roslyn
Suite 430
Greenwood Village, CO 80111 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription
Jack RiccardiDirector
Omni Bio Pharmaceutical, Inc. is the licensee of filed, but not yet issued, patents related to composition of matter and method of use for an existing FDA approved drug, Alpha 1 Antitrypsin (AAT), for treating organ transplantation, including islet transplantation for the treatment of diabetes and b.....See More See More

Auditor: Hein & Associates LLP
Legal Advisor: Perkins Coie LLP
$USD, In whole numbers,
except marked * or %
201420132012201120102009
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: